CD200 and cancer: An in silico screen for shared genome-wide association study signals across hundreds of phenotypes identified pleiotropic opposing effects on the lifetime risk for cancer and autoimmune disease on gene variants for CD200R1, CD200, and Dok2 (10, 12).